+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Enzyme; Application; End User, and Country

  • ID: 5180791
  • Report
  • September 2020
  • Region: Asia Pacific
  • 69 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amniox Medical, inc
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
  • MORE
The Asia Pacific amniotic membrane market was valued at US$ 279.28 million in 2019 and is projected to reach US$ 503.69 million by 2027; it is expected to grow at a CAGR of 7.8% during the forecast period.

The growth of the Asia Pacific amniotic membrane market is mainly attributed to the factors such as rise in applications of amniotic membrane and growing geriatric population. However, the challenges in using amniotic membranes such as lack of adherence to biological site and issues with preservation are likely to restrain the market growth during the forecast period.

Amniotic membrane transplantation technique has brought revolutionary changes in reconstructive eye surgery. Fast FDA approvals for amniotic membrane-based products such as suspensions and allografts to treat surgical wounds contribute to the growth of the amniotic membrane market. Factors such as rising R&D investments in stem cell and regenerative medicine using cryopreservation technology would fuel the market growth. In the coming years, the market for the amniotic membrane will develop significantly in the Asia Pacific region due to the rise in the patient population, and the increase in healthcare spending. Most of the countries in Asia Pacific are economically developing disposable income gradually. Various multinational companies are heavily investing in this region, and the rising number of AMT procedures in India and China are supporting growth of the amniotic membrane market.

Based on enzyme, the Asia Pacific amniotic membrane market is segmented into cryopreserved amniotic membrane and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held a larger share of the market in 2019; whereas, the dehydrated amniotic membrane segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on application, the Asia Pacific amniotic membrane market is segmented into surgical wounds, ophthalmology, and other. The surgical wounds segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR of in the market during the forecast period.

Based on end user, the Asia Pacific amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and research institute and academic institutes. The hospitals segment held the largest share of the market in 2019; however, the ambulatory surgical centers segment is estimated to register the highest CAGR in the market during the forecast period.

Indian Council of Medical Research (ICMR), World Health Organization (WHO), and National Hospital Ambulatory Medical Care are among the major primary and secondary sources for the Asia Pacific Amniotic membrane market included in the report.

Reasons to Buy
  • To understand the Asia Pacific amniotic membrane market scope and identify market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific amniotic membrane market.
  • Efficiently plan M&A and partnership deals in Asia Pacific amniotic membrane market by identifying market segments with the most promising probable sales.
  • Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific amniotic membrane market.
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amniox Medical, inc
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Amniotic Membrane Market- By Enzyme
1.3.2 Asia Pacific Amniotic Membrane Market- By Application
1.3.3 Asia Pacific Amniotic Membrane Market - By End User
1.3.4 Asia Pacific Amniotic Membrane Market- By Geography

2. Amniotic Membrane Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Amniotic Membrane Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.3 Expert Opinions

5. Asia Pacific Amniotic Membrane Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Applications of Amniotic Membrane
5.1.2 Rising Number of Target Patient Population
5.2 Market Restraints
5.2.1 Challenges in Using Amniotic Membranes
5.3 Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Development of Amniotic Membrane-Derived Products
5.5 Impact Analysis

6. Amniotic Membrane Market - Asia Pacific Analysis
6.1 Amniotic Membrane Market Revenue Forecast And Analysis

7. Amniotic Membrane Market Analysis - By Enzyme
7.1 Overview
7.2 Amniotic Membrane Market Revenue Share, by Enzyme (2019 and 2027)
7.3 Cryopreserved Amniotic Membrane
7.3.1 Overview
7.3.2 Cryopreserved Amniotic Membrane: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Dehydrated Amniotic Membrane
7.4.1 Overview
7.4.2 Dehydrated Amniotic Membrane: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)

8. Amniotic Membrane Market Analysis - By Application
8.1 Overview
8.2 Amniotic Membrane Market Revenue Share, by Application (2019 and 2027)
8.3 Surgical Wounds
8.3.1 Overview
8.3.2 Surgical Wounds Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Ophthalmology
8.4.1 Overview
8.4.2 Ophthalmology: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Other Applications
8.5.1 Overview
8.5.2 Other Applications: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)

9. Amniotic Membrane Market Analysis - By End User
9.1 Overview
9.2 Amniotic Membrane Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Ambulatory Surgical Centres: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Research Institute and Academic Institutes
9.5.1 Overview
9.5.2 Research Institute and Academic Institutes : Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Specialty Clinics
9.6.1 Overview
9.6.2 Speciality Clinics: Amniotic Membrane Market - Revenue and Forecast to 2027 (US$ Million)

10. Amniotic Membrane Market Analysis And Forecasts To 2027 - Asia Pacific Analysis
10.3 Asia-Pacific: Amniotic Membrane Market
10.3.1 Overview
10.3.2 Asia-Pacific: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia-Pacific: Amniotic Membrane Market, by Country, 2019 & 2027 (%)
10.3.7 China: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Amniotic Membrane Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia Amniotic Membrane Market, by Enzyme - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia Amniotic Membrane Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia Amniotic Membrane Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Asia Pacific Amniotic Membrane Market
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles
13.2 Integra Life Sciences Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.4 MiMedx
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organogenesis Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Smith & Nephew
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix
14.1 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • Amniox Medical, inc
  • Integra Life Sciences Corporation
  • MiMedx
  • Organogenesis Inc.
  • Smith & Nephew
Note: Product cover images may vary from those shown
Adroll
adroll